By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kyowa Hakko 

767 3rd Ave., 19th Floor

New York  New York  10017  U.S.A.
Phone: 212-319-5353 Fax: 212-421-1283


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Pharmagene Laboratories Limited  Phase ZERO(TM) products and services.





Company News
Drugmakers Like Merck & Co., Inc. (MRK), Kyowa Hakko Turn To Coffee For New Parkinson’s And Alzheimer’s Treatments 3/17/2014 8:04:37 AM
Dicerna Pharmaceuticals Snags Deal With Japan's Kyowa Hakko to Develop RNAi Cancer Treatments; Dicerna Will Get $4 Million Upfront, $120 Million in Milestone Payments 1/4/2010 7:35:44 AM
Kyowa Hakko: Brain Imaging Study Confirms Cognizin(R) Citicoline Boosts Mental Function 6/8/2009 10:52:19 AM
Sanofi (France) (SAN.PA) Signs $315 Million Deal with Kyowa Hakko 5/20/2009 6:26:56 PM
Arana Therapeutics and Kyowa Hakko to Co-develop Anti-cancer Drug; Agreement Worth Up to $8M 4/24/2008 8:03:49 AM
Amgen (AMGN) Buys Licensing Rights from Kyowa Hakko; Amgen to Pay $100M Upfront 3/6/2008 7:07:08 AM
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002) 2/28/2008 7:50:13 AM
ArQule, Inc. (ARQL) Receives $3 Million Milestone from Kyowa Hakko 2/6/2008 8:45:30 AM
Kyowa Hakko Nine-Month Operating Income Up 20.6%; Raises Full-year Forecasts 1/30/2008 9:22:28 AM
Kyowa Hakko Interim Operating Income up 25.2% 10/29/2007 11:52:50 AM
123
//-->